.Nature Medication, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antibody-- drug conjugate (ADC) tisotumab vedotin led to improved progression-free and also total survival, triggering FDA approval and also a brand-new therapy possibility for clients.